Determination of salvianolic acid C in rat plasma using liquid chromatography–mass spectrometry and its application to pharmacokinetic study |
| |
Authors: | Junke Song Wen Zhang Jialin Sun Xue Zhang Xiaona Xu Li Zhang Zhangying Feng Guanhua Du |
| |
Institution: | 1. State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;2. Pharmacy Department of the Affiliated Hospital of Qingdao University, Qingdao, China;3. The Fourth Hospital of Hebei Medical University, Shijiazhuang, China |
| |
Abstract: | A sensitive and reliable LC‐ESI‐MS method for the determination of salvianolic acid C in rat plasma has been developed and validated. Plasma samples were prepared by liquid–liquid extraction with ethyl acetate and separated on a Zorbax SB‐C18 column (3.5 µm, 2.1 × 100 mm) at a flow rate of 0.3 mL/min using acetonitrile–water as mobile phase. The detection was carried out by a single quadrupole mass spectrometer with electrospray ionization source and selected ion monitoring mode. Linearity was obtained for salvianolic acid C ranging from 5 to 1000 ng/mL. The intra‐ and inter‐day precisions (RSD, %) didn't exceed 9.96%, and the accuracy (RE, %) were all within ±3.64%. The average recoveries of the analyte and internal standard were >89.13%. Salvianolic acid C was proved to be stable during all sample storage, preparation and analytic procedures. The validated method was successfully applied to pharmacokinetic study after oral and intravenous administration of salvianolic acid C to rats. The absolute oral bioavailability of salvianolic acid C was 0.29 ± 0.05%. This method was further applied to simultaneous determination of salvianolic acid A, salvianolic acid B and salvianolic acid C in rat plasma and showed good practicability. Copyright © 2015 John Wiley & Sons, Ltd. |
| |
Keywords: | salvianolic acid C LC– MS pharmacokinetics bioavailability dose proportionality |
|
|